A new /Mactamase inhibitor, SYN-1012, with a penem skeleton was synthesized and its biological activity compared with clavulanic acid, sulbactam, tazobactam and BRL-42715. The /Mactamase inhibitory activity of SYN-1012was comparable to BRL-42715. Clavulanate and penam sulphones (sulbactam and tazobactam) were more active against TEM-1and OXA-1,but were less active against TEM-3 and cephalosporinase (Case) than SYN-1012. In combination with piperacillin,
Therefore, the need for broad-spectrum /Mactamase inhibitors with suitable physico-chemical and pharmacodynamic profile for oral as well as parenteral use remains a subject of high interest amongmedicinal chemists. APR. 1997 The extraordinary /Mactamase inhibitory activity of penem skeleton, as seen in the BRL-42715 and its analogs1°~14>5 prompted us to prepare related penem derivatives for biological evaluation. Some of our earlier work had focused on synthesis ofpenamsulphones with substitutions similar to that of BRL-42715series at C-6 position15 '16 
Bacterial Strains
Clinical isolates were collected between 1987~92 from various medical centers in Japan. Identification of each culture was done by conventional methods: Gram-negative bacilli by API 20E (Analytab Products, Plainview, NY.) and NF systems (Remel, Lenexa, Kans.), and staphylococci by Staph Trac (Analytab Products). All isolates were stored frozen in skim milk at -80°C.
Media and Chemicals
All media were prepared in distilled deionized (DI) water. Mueller-Hinton (MH) medium was purchased from Becton Dickinson Microbiology Systems, Cockeysville, MD.All control antimicrobial agents were purchased from Sigma Chemical Co., St. Louis, MO.
Clavulanic acid was isolated and purified from the marketed formulation.
Tazobactam, sulbactam, SYN-1012 and BRL-42715 were synthesized in our laboratory.
In Vitro Susceptibility Testing The in vitro antibacterial activities were determined by the agar dilution method, as recommendedby the National Committee for Clinical Laboratory Standards1 8).
Mueller-Hinton II agar (MHA) plates containing the antibiotics at 0.10 to 200^g/ml (alone or in combination with 5 jUg/ml of the /Mactamase inhibitor) were prepared.
Inocula were adjusted to a density of 107 CFU/mland approximately 3 /il were applied to the agar surface with a Steers replicator. The test plates were incubated at 37°C for 18 hours. The minimuminhibitory concentration (MIC) was defined as the lowest concentration of antimicrobial agent that completely inhibited visible growth of the organism.
Isolation of /?-Lactamases 351
The overnight culture grown in MHBwas diluted 100-fold into the same broth that was prewarmed at 37°C. The diluted culture (100ml in 500ml Erlenmeyer flask) was incubated for 4 hours at 37°C and 200rpm.
The cells were cetrifuged at 15,000$ for 15 minutes at 37°C, the pellet was washed once with 50mMphosphate
buffer (pH 7.0) and resuspended (1010cells/ml) in the buffer. The cells were disrupted by sonication (3 x 30 seconds pulse at 0°C) and cell debris was removed by centrifugation (15,000$, 15 minutes, 4°C). The supernatant was used as the crude extract containing the /?-lactamase.
-Lactamase Inhibitory Activity
The /Mactamase inhibitory activity was performed by UVspectrophotometry using freshly prepared antibiotic solutions in 50mMphosphate buffer at pH 7. The assay was run at 30°C, and the following wavelengths were used; 235 nm for ampicillin and 260 nm for cephaloridine. At the various concentrations of inhibitors (up to 10/ig/ml), tazobactam, sulbactam, clavulanic acid, SYN1012, and BRL42715 were tested for the inhibitory activity of the cephaloridine hydrolysis rate for TEM-3 Male ddy mice weighing 18~22 g were purchased from SLC, Shizuoka, Japan. Blood was collected from the cut axillary region of humanely killed mice. Mouse kidney Tazobactamwas inferior to SYN-1012 in all cases. In comparisonto tazobactam, SYN-1012 and BRL-42715 were relatively unstable in human and mouse plasma, and in mouse liver and kidney homogenates (Fig.  3) . SYN-1012 and BRL-42715were similar in their instability in mouse plasma and mouseliver homogenate (Fig. 3a and3c) , but SYN-1012was marginally more stable in human plasma and in mouse kidney homogenate (Fig. 3b and3d) . The stability of BRL-42715 analogs in human kidney homogenate has been reported to vary considerably12). In general 5-R enatiomers were more active than 5-S enatiomers. Althoughthe 5-R enantiomer of BRL-42715 has been reported to berelatively stable in human kidney homogenate, it degraded rather rapidly in mouse kidney homogenate when tested in our laboratory. and BRL-42715 were found to recede rapidly and were undetectable after 1 hour (Fig. 4) .
Although SYN-1012 has very good /Mactamase inhibitory activity its instability in the plasma, kidney and liver homogenates, and fairly short T1/2 do not seem to favor further development of this compound.
